Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex
CORRECTION article
Corrigendum: Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex
Provisionally accepted- Cedars Sinai Medical Center, Los Angeles, United States
Corrigendum on: Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex. (PMC9751428; PMID 36532738). In the published article, there was an error in Figure 4 as published. One of the lanes (referring to eIF4E) was mistakenly replaced with a control lane (third panel from the top in Figure 4A). The corrected Figure 4A and its caption appear below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: COVID-19, OC43, SARS-CoV-2, Coronavirus, eIF4F, Translation initiation complex, Vero E6
Received: 14 Nov 2024; Accepted: 26 Nov 2024.
Copyright: © 2024 Ronai. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Zeev Ronai, Cedars Sinai Medical Center, Los Angeles, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.